EPR22-117: Evaluation of the Influence of the BRAF V600E Mutation and of the Microsatellite Instability on the Overall Survival (OS) of Metastatic CRC Patients Based on Real World Data

Authors:
Aparna Parikh Massachusetts General Hospital Cancer Center, Boston, MA

Search for other papers by Aparna Parikh in
Current site
Google Scholar
PubMed Close
 MD
,
Maria Cecilia Vieira Pfizer Inc., New York City, NY

Search for other papers by Maria Cecilia Vieira in
Current site
Google Scholar
PubMed Close
 MSc
,
Benjamin Li Pfizer Inc., New York City, NY

Search for other papers by Benjamin Li in
Current site
Google Scholar
PubMed Close
 PhD
,
Neil Lamarre Genesis Research, Hoboken, NJ

Search for other papers by Neil Lamarre in
Current site
Google Scholar
PubMed Close
 PhD
,
Anup Abraham Genesis Research, Hoboken, NJ

Search for other papers by Anup Abraham in
Current site
Google Scholar
PubMed Close
 MPH
,
Craig Parzynski Genesis Research, Hoboken, NJ

Search for other papers by Craig Parzynski in
Current site
Google Scholar
PubMed Close
 MS
, and
Michelle Edwards Pfizer Inc., New York City, NY

Search for other papers by Michelle Edwards in
Current site
Google Scholar
PubMed Close
 PharmD
Volume/Issue:
Volume 20: Issue 3.5
Online Publication Date:
31 Mar 2022
DOI:
https://doi.org/10.6004/jnccn.2021.7264
Restricted access

Corresponding Author: Anup Abraham, MPH
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2022 by the National Comprehensive Cancer Network 2022
Article Category:
Abstract
Print Publication Date:
31 Mar 2022
Online Publication Date:
31 Mar 2022

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 918 555 31
PDF Downloads 0 0 0
EPUB Downloads 0 0 0